Evidence-based Clinical Prioritization of Embryos with Mosaic Results: a Systematic Review and Meta-analysis
Overview
Reproductive Medicine
Affiliations
Purpose: The purpose of this review and meta-analysis is to standardize the practice of mosaic embryo transfer, based on the current available evidence.
Methods: This is a systematic review and meta-analysis. Relevant studies published were comprehensively selected using PubMed, Medline, Embase, and CENTRAL until 5 March 2021. Prospective and retrospective studies reporting the genetic analysis and clinical outcomes of mosaic embryo transfer were included. Risk of bias assessment was based on the Newcastle-Ottawa scale for the non-randomized studies. The primary and secondary outcomes were combined ongoing pregnancy and live birth rate and miscarriage rate, respectively.
Results: There were no differences between low and high mosaic embryos when a cut-off of 40% was used in terms of OP/LBR and SAB. However, low mosaics with a cut-off of 50% compared to high mosaics showed a significantly higher OP/LBR in the NGS but not in the a-CGH group, and a significantly lower risk of SAB. No differences were noted between mosaic monosomies versus trisomies and single versus double mosaics for both OP/LBR and SAB. Finally, segmental mosaics showed a higher OP/LBR and a lower SAB compared to whole chromosomes, and single and double mosaics had a higher OP/LBR compared to complex mosaics.
Conclusions: A cut-off of 50% in defining low versus high mosaic embryos is preferable to a threshold of 40% when using NGS platform. No priority was established for mosaic trisomies over monosomies. Single and double mosaics must be preferred over complex mosaics and segmental mosaics must be preferred over whole chromosome mosaics. These results should be interpreted in the context of specific chromosomes involved in the mosaicism.
Evolution of Minimally Invasive and Non-Invasive Preimplantation Genetic Testing: An Overview.
Moustakli E, Zikopoulos A, Skentou C, Bouba I, Dafopoulos K, Georgiou I J Clin Med. 2024; 13(8).
PMID: 38673433 PMC: 11050362. DOI: 10.3390/jcm13082160.
Mosaicism in preimplantation embryos: Are we overinterpreting the results?.
Schattman G F S Rep. 2023; 4(3):251.
PMID: 37719096 PMC: 10504555. DOI: 10.1016/j.xfre.2023.07.001.
Martin A, Mercader A, Dominguez F, Quinonero A, Perez M, Gonzalez-Martin R Front Mol Biosci. 2023; 10:1180689.
PMID: 37122560 PMC: 10140421. DOI: 10.3389/fmolb.2023.1180689.
Sanders K, Griffin D, Martell H, Blazek J, Large M, Gordon T J Assist Reprod Genet. 2023; 40(3):653-664.
PMID: 36708429 PMC: 10033805. DOI: 10.1007/s10815-022-02678-8.
ESHRE survey results and good practice recommendations on managing chromosomal mosaicism.
De Rycke M, Capalbo A, Coonen E, Coticchio G, Fiorentino F, Goossens V Hum Reprod Open. 2022; 2022(4):hoac044.
PMID: 36349144 PMC: 9637425. DOI: 10.1093/hropen/hoac044.